Amidogen, oxo- en es it fr

Amidogen, oxo- Brand names, Amidogen, oxo- Analogs

Amidogen, oxo- Brand Names Mixture

  • Aldoril 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Aldoril 25 Tab (Hydrochlorothiazide + Methyldopa)
  • Apo Methazide 15 (Hydrochlorothiazide + Methyldopa)
  • Apo Methazide 25 (Hydrochlorothiazide + Methyldopa)
  • Novo-Doparil 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Novo-Doparil 25 Tab (Hydrochlorothiazide + Methyldopa)
  • Pms-Dopazide 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Pms-Dopazide-25 Tab (Hydrochlorothiazide + Methyldopa)
  • Supres 150 Tab (Chlorothiazide + Methyldopa)
  • Supres 250 Tab (Chlorothiazide + Methyldopa)

Amidogen, oxo- Chemical_Formula


Amidogen, oxo- RX_link

Amidogen, oxo- fda sheet

Amidogen,_oxo- FDA

Amidogen, oxo- msds (material safety sheet)

Amidogen,_oxo- MSDS

Amidogen, oxo- Synthesis Reference

No information avaliable

Amidogen, oxo- Molecular Weight

30.0061 g/mol

Amidogen, oxo- Melting Point

-163.6 oC

Amidogen, oxo- H2O Solubility

9.49E+004 mg/L

Amidogen, oxo- State


Amidogen, oxo- LogP


Amidogen, oxo- Dosage Forms

Cream; Drops; Gas; Liquid; Lotion; Ointment; Powder; Tablet

Amidogen, oxo- Indication

For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure

Amidogen, oxo- Pharmacology

Persistent pulmonary hypertension of the newborn (PPHN) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (MAS), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (CDH), and pulmonary hypoplasia. In these states, pulmonary vascular resistance (PVR) is high, which results in hypoxemia secondary to right-to-left shunting of blood through the patent ductus arteriosus and foramen ovale. In neonates with PPHN, Nitric oxide improves oxygenation (as indicated by significant increases in PaO2). Nitric oxide appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary vessels in better entilated areas of the lung, redistributing pulmonary blood flow away from lung regions with low ventilation/perfusion (V/Q) ratios toward regions with normal ratios.

Amidogen, oxo- Absorption

Nitric oxide is absorbed systemically after inhalation.

Amidogen, oxo- side effects and Toxicity

No information avaliable

Amidogen, oxo- Patient Information

No information avaliable

Amidogen, oxo- Organisms Affected

Humans and other mammals